228
Views
14
CrossRef citations to date
0
Altmetric
Articles

Effects of Phytosterol Supplementation on Serum Levels of Lipid Profiles, Liver Enzymes, Inflammatory Markers, Adiponectin, and Leptin in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

ORCID Icon, , &
Pages 651-658 | Received 19 Feb 2018, Accepted 15 Apr 2018, Published online: 16 May 2018

References

  • Obika M, Hirofumi N. Diagnosis and evaluation of nonalcoholic fatty liver disease. Exp Diabetes Res. 2011;2012:1–12. doi:10.1155/2012/145754.
  • Al-Busafi SA, Bhat M, Wong P, Ghali P, Deschenes M. Antioxidant therapy in nonalcoholic steatohepatitis. Hepatitis Research and Treatment. 2012;2012:1–8. doi:10.1155/2012/947575.
  • Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274–85. doi:10.1111/j.1365-2036.2011.04724.x. PMID:21623852.
  • Riquelme A, Arrese M, Soza A, Morales A, Baudrand R, Perez-Ayuso RM, Gonzalez R, Alvarez M, Hernandez V, Garcia-Zattera MJ, et al. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int. 2009;29:82–88. doi:10.1111/j.1478-3231.2008.01823.x. PMID:18647235.
  • Lomonaco R, Sunny NE, Bril F, Cusi K. Nonalcoholic fatty liver disease: current issues and novel treatment approaches. Drugs. 2013;73:1–14. doi:10.1007/s40265-012-0004-0. PMID:23329465.
  • Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7:195–203. doi:10.1038/nrgastro.2010.21. PMID:20195271.
  • Finelli C, Tarantino G. Is there any consensus as to what diet or lifestyle approach is the right one for NAFlD patients? J Gastrointestin Liver Dis. 2012;21:293–302.
  • Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med. 2008;14:72–81. doi:10.1016/j.molmed.2007.12.003. PMID:18218340.
  • Vos MB, McClain CJ. Nutrition and nonalcoholic fatty liver disease in children. Curr Gastroenterol Rep. 2008;10:308–15. doi:10.1007/s11894-008-0061-4. PMID:18625143.
  • Pagano C, Soardo G, Esposito W, Fallo F, Basan L, Donnini D, Federspil G, Sechi LA, Vettor R. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol. 2005;152:113–8. doi:10.1530/eje.1.01821. PMID:15762194.
  • Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism. 2006;55:1604–9. doi:10.1016/j.metabol.2006.07.021. PMID:17142131.
  • Fujii H, Kawada N. Inflammation and fibrogenesis in steatohepatitis. J Gastroenterol. 2012;47(3):215–25. doi:10.1007/s00535-012-0527-x. PMID:22310735.
  • Ba sarano glu M, Ormeci N. Nonalcoholic fatty liver disease: diagnosis, pathogenesis, and management. Turk J Gastroenterol. 2014;25:127–32. doi:10.5152/tjg.2014.7675. PMID:25003670.
  • Bashiri A, Tavallaee G, Li L, Ng DS. Emerging role of cellular cholesterol in the pathogenesis of nonalcoholic fatty liver disease. Curr Opin Lipidol. 2013;24:275–6. doi:10.1097/MOL.0b013e328361633e. PMID:23652472.
  • Musso G, Gambino R, Cassader M. Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis. Prog Lipid Res. 2013;52:175–91.
  • Takeshita Y, Takamura T, Kita Y, et al. Efficacy of ezetimibe for the treatment of non alcoholic fatty liver disease: a randomized controlled trial. J Hepatol. 2011;54:S346. doi:10.1016/S0168-8278(11)60870-2.
  • Jones PJ, AbuMweis SS. Phytosterols as functional food ingredients: linkages to cardiovascular disease and cancer. Curr Opin Clin Nutr Metab Care. 2009;12:147–51. doi:10.1097/MCO.0b013e328326770f. PMID:19209468.
  • Baumgartner S, Mensink RP, Plat J. Plant sterols and stanols in the treatment of dyslipidemia: new insights into targets and mechanisms related to cardiovascular risk. Current pharmaceutical design. 2011;17:922–32. doi:10.2174/138161211795428795. PMID:21418032.
  • Ostlund RE Jr. Phytosterols in human nutrition. Annual review of nutrition. 2002;22:533–49. doi:10.1146/annurev.nutr.22.020702.075220. PMID:12055357.
  • Ostlund RE Jr, McGill JB, Zeng C-M, Covey DF, Stearns J, Stenson WF, Spilburg CA. Gastrointestinal absorption and plasma kinetics of soy Δ5-phytosterols and phytostanols in humans. Am J Physiol Endocrinol Metab. 2002;282:911–6. doi:10.1152/ajpendo.00328.2001.
  • The Myocardial Infarction Genetics Consortium Investigators. Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med. 2014;371:2072–82. doi:10.1056/NEJMoa1405386. PMID:25390462.
  • Wouters K, van Gorp PJ, Bieghs V, Gijbels MJ, Duimel H, Lütjohann D, Kerksiek A, van Kruchten R, Maeda N, Staels B, et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology. 2008;48:474–86. doi:10.1002/hep.22363. PMID:18666236.
  • Qin Y, Tian Y. Preventive effects of chronic exogenous growth hormone levels on diet-induced hepatic steatosis in rats. Lipids health Dis. 2010;9:1–78. doi:10.1186/1476-511X-9-78. PMID:20053284.
  • Hamad EM, Taha SH, Dawood AGIA, Sitohy MZ. Protective effect of whey proteins against nonalcoholic fatty liver in rats. Lipids Health Dis. 2011;10:1–57. doi:10.1186/1476-511X-10-57.
  • Janevski M, Antonas KN, Sullivan-Gunn MJ, McGlynn MA, Lewandowski PA. The effect of cocoa supplementation on hepatic steatosis, reactive oxygen species and LFABP in a rat model of NASH. Comp Hepatol. 2011;10(1):1–13. doi:10.1186/1476-5926-10-10. PMID:21729291.
  • Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003;37(4):909–16. doi:10.1053/jhep.2003.50132. PMID:12668986.
  • Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 2009;48(1):1–26. doi:10.1016/j.plipres.2008.08.001. PMID:18824034.
  • Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease. HEPATOLOGY. 2007;46:1081–90. doi:10.1002/hep.21763. PMID:17654743.
  • Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H, et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. HEPATOLOGY. 2009;50:1827–38. doi:10.1002/hep.23229. PMID:19937697.
  • Ioannou GN, Morrow OB, Connole ML, Lee SP. Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population. HEPATOLOGY. 2009;50:175–84. doi:10.1002/hep.22941. PMID:19441103.
  • Heinemann T, Kullak-Ublick G-A, Pietruck B, von Bergmann K. Mechanisms of action of plant sterols on inhibition of cholesterol absorption: comparison of sitosterol and sitostanol. Eur J Clin Pharmacol. 1991;40(Suppl):S59–63. doi:10.1007/BF03216292. PMID:2044646.
  • Mattson FH, Volpenhein RA, Erikson BA. Effect of plant sterol esters on the absorption of dietary cholesterol. J Nutr. 1977;107:1139–46. doi:10.1093/jn/107.7.1139. PMID:874557.
  • Plat J, Mensink RP. Effects of plant stanol esters on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase mRNA expression in mononuclear blood cells of healthy men and women. FASEB J. 2002;16(2):258–60. doi:10.1096/fj.01-0653fje. PMID:11772951.
  • Farquhar JW, Smith RE, Dempsey ME. The effect of beta sitosterol on the serum lipids of young men with arteriosclerotic heart disease. Circulation. 1956;14:77–82. doi:10.1161/01.CIR.14.1.77. PMID:13356460.
  • Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med. 1995;333:1308–12. doi:10.1056/NEJM199511163332002. PMID:7566021.
  • Klingberg S, Ellegård L, Johansson I, Hallmans G, Weinehall L, Andersson H, Winkvist A. Inverse relation between naturally occurring dietary plant sterols and serum cholesterol in northern Sweden. Am J Clin Nutr. 2008;87:993–1002. doi:10.1093/ajcn/87.4.993. PMID:18400724.
  • Wang P, Chen YM, He LP, Chen CG, Zhang B, Xue WQ, Su YX. Association of natural intake of dietary plant sterols with carotid intima-media thickness and blood lipids in Chinese adults: a cross-section study. PLoS ONE. 2012;7:327–36.
  • Andersson SW, Skinner J, Ellegård L, Welch AA, Bingham S, Mulligan A, Andersson H, Khaw KT. Intake of plant sterols is inversely related to serum cholesterol concentration in men and women in the EPIC Norfolk population: a cross-sectional study. Eur J Clin Nutr. 2004;58:1378–85. doi:10.1038/sj.ejcn.1601980. PMID:15054420.
  • Lin X, Racette SB, Lefevre M, Spearie CA, Most M, Ma L, Ostlund RE Jr. The effects of phytosterols present in natural food matrices on cholesterol metabolism and LDL-cholesterol: a controlled feeding trial. Eur J Clin Nutr. 2010;64:1481–7. doi:10.1038/ejcn.2010.180. PMID:20808333.
  • Jones PJ, Vanstone CA, Raeini-Sarjaz M, St-Onge MP. Phytosterols in low- and nonfat beverages as part of a controlled diet fail to lower plasma lipid levels. J Lipid Res. 2003;44:1713–9. doi:10.1194/jlr.M300089-JLR200. PMID:12730296.
  • Clifton PM, Noakes M, Sullivan D, Erichsen N, Ross D, Annison G, Fassoulakis A, Cehun M, Nestel P. Cholesterol-lowering effects of plant sterol esters differ in milk, yoghurt, bread and cereal. Eur J Clin Nutr. 2004;58:503–9. doi:10.1038/sj.ejcn.1601837. PMID:14985690.
  • Mensink RP, Ebbing S, Lindhout M, Plat J, van Heugten MM. Effects of plant stanol esters supplied in low-fat yoghurt on serum lipids and lipoproteins,non-cholesterol sterols and fat soluble antioxidant concentrations. Atherosclerosis. 2002;160:205–13. doi:10.1016/S0021-9150(01)00562-7. PMID:11755939.
  • Korpela R, Tuomilehto J, Hogstrom P, Seppo L, Piironen V, Salo-Väänänen P, Toivo J, Lamberg-Allardt C, Kärkkäinen M, Outila T, et al. Safety aspects and cholesterol-lowering efficacy of low fat dairy products containing plant sterols. Eur J Clin Nutr. 2006;60:633–42. doi:10.1038/sj.ejcn.1602362. PMID:16404415.
  • Doornbos AM, Meynen EM, Duchateau GS, van der Knaap HC, Trautwein EA. Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 2006;60:325–33. doi:10.1038/sj.ejcn.1602318. PMID:16234829.
  • Noakes M, Clifton PM, Doornbos AM, Trautwein EA. Plant sterol ester-enriched milk and yoghurt effectively reduce serum cholesterol in modestly hypercholesterolemic subjects. Eur J Nutr. 2005;44:214–22. doi:10.1007/s00394-004-0513-z. PMID:15316827.
  • Jauhiainen T, Salo P, Niittynen L, Poussa T, Korpela R. Effects of low-fat hard cheese enriched with plant stanol esters on serum lipids and apolipoprotein B in mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 2006;60:1253–7. doi:10.1038/sj.ejcn.1602445. PMID:16721398.
  • Algorta Pineda J, Chinchetru Ranedo MJ, Aguirre Anda J, Francisco Terreros S. [Hypocholesteremic effectiveness of a yogurt containing plant stanol esters]. Rev Clin Esp. 2005;205:63–6. doi:10.1157/13072497. PMID:15766477.
  • Sialvera TE, Pounis GD, Koutelidakis AE, Richter DJ, Yfanti G, Kapsokefalou M, Goumas G, Chiotinis N, Diamantopoulos E, Zampelas A. Phytosterols supplementation decreases plasma small and dense LDL levels in metabolic syndrome patients on a westernized type diet. Nutr Metab Cardiovasc Dis. 2012;22:843–8. doi:10.1016/j.numecd.2010.12.004. PMID:21316934.
  • Demonty I, Ras RT, van der Knaap HC, Meijer L, Zock PL, Geleijnse JM, Trautwein EA. The effect of plant sterols on serum triglyceride concentrations is dependent on baseline concentrations:a pooled analysis of 12 randomised controlled trials. Eur J Nutr. 2013;52:153–60. doi:10.1007/s00394-011-0297-x. PMID:22252793.
  • Naumann E, Plat J, Kester ADM, Mensink RP. The baseline serum lipoprotein profile is related to plant stanol induced changes in serum lipoprotein cholesterol and triacylglycerol concentrations. J Am Coll Nutr. 2008;27:117–26. doi:10.1080/07315724.2008.10719683. PMID:18460490.
  • Gylling H, Miettinen TA. Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia. 1994;37:773–80. doi:10.1007/BF00404334. PMID:7988779.
  • Racette SB, Lin X, Lefevre M, Spearie CA, Most MM, Ma L, Ostlund RE Jr. Dose effects of dietary phytosterols on cholesterol metabolism: a controlled feeding study. Am J Clin Nutr. 2010;91:32–8. doi:10.3945/ajcn.2009.28070. PMID:19889819.
  • Meguro S, Higashi K, Hase T, Honda Y, Otsuka A, Tokimitsu I, Itakura H. Original communication. Solubilization of phytosterols in diacylglycerol versus triacylglycerol improves the serum cholesterollowering effect. Eur J Clin Nutr. 2001;55:513–7. doi:10.1038/sj.ejcn.1601173. PMID:11464223.
  • Child P, Kuksis A. Investigation of the role of micellar phospholipid in the preferential uptake of cholesterol over sitosterol by dispersed rat jejunal villus cells. Biochem Cell Biol. 1986;64:847–53. doi:10.1139/o86-113. PMID:3768170.
  • Child P, Kuksis A. Critical role of ring structure in the differential uptake of cholesterol and plant sterols by membrane preparations in vitro. J Lipid Res. 1983;24:1196–209. PMID:6605404.
  • Wasan KM, Wong J, Kwong M, Pritchard PH. Assessing plasma lipid levels, body weight, and hepatic and renal toxicity following chronic oral administration of a water soluble phytostanol compound, FM-VP4, to gerbils. J Pharm Pharm Sci. 2001;4.3:228–34.
  • Radika MK, Viswanathan P, Anuradha CV. Nitric oxide mediates the insulin sensitizing effects of β-sitosterol in high fat diet-fed rats. Nitric Oxide. 2013;32:43–53. doi:10.1016/j.niox.2013.04.007. PMID:23624268.
  • Demori I, Voci A, Fugassa E, Burlando B. Combined effects of high-fat diet and ethanol induce oxidative stress in rat liver. Alcohol. 2006;40:185–91. doi:10.1016/j.alcohol.2006.12.006. PMID:17418698.
  • Baskar AA, Ignacimuthu S, Paulraj GM, Al Numair KS. Chemopreventive potential of b-Sitosterol in experimental colon cancer model – an in vitro and In vivo study, BMC Complement. Altern Med. 2010;10(1):24.
  • Jayaprakasha GK, Mandadi KK, Poulose SM, Jadegoud Y, Nagana Gowda GA, Patil BS. Inhibition of colon cancer cell growth and antioxidant activity of bioactive compounds from Poncirustrifolata in rat. Bioorg Med Chem. 2007;15:4923–32. doi:10.1016/j.bmc.2007.04.044. PMID:17512744.
  • Jiménez-Santos Ma A, et al. Coenzyme Q 10 supplementation improves metabolic parameters, liver function and mitochondrial respiration in rats with high doses of atorvastatin and a cholesterol-rich diet. Lipids in health and disease. 2014;13.1:22. doi:10.1186/1476-511X-13-22.
  • Nikroo H, Hosseini SRA, Hamidreza S, Mohsen N. The effect of diet and aerobic training on serum aminotransferases levels in patients with non-alcoholic steatohepatitis. 2011;51–60.
  • Gagliardi ACM, Maranhão RC, de Sousa HP, Schaefer EJ, Santos RD. Effects of margarines and butter consumption on lipid profiles, inflammation markers and lipid transfer to HDL particles in free-living subjects with the metabolic syndrome. European journal of clinical nutrition. 2010;64.10:1141–9. doi:10.1038/ejcn.2010.122.
  • Sikder K, Das N, Kesh SB, Dey S. Quercetin and β-sitosterol prevent high fat diet induced dyslipidemia and hepatotoxicity in Swiss albino mice. 2014.
  • Jenkins DJA, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R, Emam A, Parker TL, Vidgen E, Lapsley KG, et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. Jama. 2003;290.4:502–10. doi:10.1001/jama.290.4.502.
  • Devaraj S, Bryce CA, Ishwarlal J. Reduced-calorie orange juice beverage with plant sterols lowers C-reactive protein concentrations and improves the lipid profile in human volunteers. The American journal of clinical nutrition. 2006;84.4:756–61. doi:10.1093/ajcn/84.4.756.
  • Nieminen P, Mustonen AM, Lindström-Seppä P, Asikainen J, Mussalo-Rauhamaa H, Kukkonen JV. Phytosterols act as endocrine and metabolic disruptors in the European polecat (Mustela putorius). Toxicology and applied pharmacology. 2002;178.1:22–28. doi:10.1006/taap.2001.9315.
  • Micallef MA, Manohar LG. Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis. 2009;204.2:476–82. doi:10.1016/j.atherosclerosis.2008.09.020.
  • Furlan Cibele Priscila B, Rafaela da Silva M, Mário Roberto M. Conjugated linoleic acid and phytosterols counteract obesity induced by high-fat diet. Food research international. 2013;51(1):429–35. doi:10.1016/j.foodres.2012.12.023.
  • Belda BJ, Thompson JT, Eser PO, Vanden-Heuvel JP. 10e12z CLA alters adipocyte differentiation and adipocyte cytokine expression and induces macrophage proliferation. J Nutr Biochem. 2012;23:510–8. doi:10.1016/j.jnutbio.2011.02.009. PMID:21764284.
  • Ebine N, Demonty I, Jia X, Jone PJH. Plant stanol ascorbate esters reduce body weight gain through decreased energy absorption in hamsters. Int J Obes. 2006;30:751–7. doi:10.1038/sj.ijo.0803191.
  • Faber MG, Bigornia B, Mott MMS, Tanriverdi K, Morin KM, Freedman JE, Joseph L, Hess DT, Apovian CM, Vita JA, et al. Reduced adipose tissue inflammation represents an intermediate cardiometabolic phenotype in obesity. J Am Coll Cardiol. 2011;58:232–7. doi:10.1016/j.jacc.2011.01.051. PMID:21737012.
  • Marangoni F, Poli A. Phytosterols and cardiovascular health. Pharmacol Res. 2010;61:193–9. doi:10.1016/j.phrs.2010.01.001. PMID:20067836.
  • Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784–92. doi:10.1172/JCI29126. PMID:16823476.
  • Jones PJ, St-Onge MP. Phytosterols and human lipid metabolism: Efficacy, safety, and novel foods. Lipids. 2003 Apr 1;38(4):367–75. doi:10.1007/s11745-003-1071-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.